Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Spain / NCT07802392
Recruiting Not applicable

Immersive Nature-Based Wellbeing Program in Older Adults With Cognitive Impairment

NCT07802392 · tracked via the Priya Life Science Spain tracker
Sponsor
Consorci Sanitari de Terrassa
Phase
Not applicable
Started
2026-03-31
Last updated
2026-09-03

Condition(s) studied

Cognitive Dysfunction

Investigational drug(s) / intervention(s)

Immersive virtual reality program

Immersive virtual reality program: Participants receive an immersive virtual reality intervention using nature-based environments. The program consists of 10 group sessions that combine mindfulness, cognitive stimulation, and breathing techniques to promote cognitive and emotional well-being.

Study summary

This study aims to evaluate an immersive virtual reality program designed to support cognitive and emotional well-being in older adults with mild to moderate cognitive impairment. The program uses nature-based environments combined with mindfulness, cognitive stimulation, and breathing techniques. The goal is to determine whether immersive virtual reality can be a safe and effective tool to improve well-being and support active and healthy aging.

The study will be conducted in two phases. In the first phase, virtual environments will be tested in healthy participants using behavioral and physiological measures. In the second phase, 200 older adults with cognitive impairment from day care centers and residential facilities will participate in a group-based immersive virtual reality intervention consisting of 10 sessions.

Researchers will assess changes in cognitive function, emotional wellbeing, daily functioning, and quality of life before and after the intervention.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Age ≥ 65 years * Diagnosis of mild or moderate cognitive impairment * Ability to understand study procedures and follow instructions * Ability to provide informed consent (or consent provided by a legal representative) * Attendance at participating day care centers or residential facilities (Phase 2) * For Phase 1: healthy adults without cognitive impairment Exclusion Criteria: * Severe cognitive impairment or diagnosis of advanced dementia * Severe visual, auditory, or motor impairments that prevent use of virtual reality * Neurological or psychiatric conditions that may interfere with participation * History of epilepsy or conditions contraindicating virtual reality exposure * Severe behavioral disturbances or agitation * Participation in other clinical studies that may interfere with results

Primary outcome measure(s)

  • Change in cognitive function (verbal fluency and Digit Span tests) — Baseline (pre-intervention) and immediately post-intervention (1 week)
    Cognitive function is assessed using verbal fluency tasks and Digit Span tests (forward and backward). Verbal fluency evaluates language and executive function by measuring the number of words generated under specific conditions. Digit Span forward assesses attention, while Digit Span backward assesses working memory. Higher scores indicate better cognitive performance.

Trial sites (1)

FacilityCityRegionStatus
Consorci Sanitari de Terrassa Terrassa Barcelona Recruiting

More Consorci Sanitari de Terrassa trials in Spain

Treatment of Mechanical Low Back Pain With High-Intensity Focused Ultrasound (HIFU) Starting soon
Antihistamines, Amantadine and Evolution of COVID-19 Recruiting
2024 NewAnescat Register Recruiting
Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) Active, not recruiting
Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy Active, not recruiting

Other trials for the same condition

Effects of a Computerized Cognitive Stimulation Intervention Adapted to the Level of Cognitive Reserve Recruiting
Study on Cardiovascular Health, Nutrition and Physical Functioning in Older Adults in Spain Enrolling by invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07802392 on ClinicalTrials.gov ↗ ← All trials in Spain